Expert review

Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stents

EuroIntervention 2007;3:381-385 - DOI10.4244/EIJV3I3A68.

Giuseppe Biondi-Zoccai
Giuseppe G. L. Biondi-Zoccai1, MD; Pierfrancesco Agostoni2, MD; Claudio Moretti1, MD; Emanuele Meliga1,3, MD; Imad Sheiban1*, MD
1. Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy; 2. Antwerp Cardiovascular Institute Middelheim, AZ Middelheim, Antwerp, Belgium; 3. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands

The safety of drug-eluting stents (DES) in patients undergoing percutaneous coronary intervention has been questioned in several independent meta-analyses (i.e., systematic reviews of primary research studies emp

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

coronary artery diseaseclinical researchevidence-based medicinemeta-analysissystematic review
Read next article
Effectiveness and safety of paclitaxel-eluting stents in patients with ST-segment elevation acute myocardial infarction

Latest news